Medical News Summary: Many promising new cancer drugs are in late-stage trials
About: Many promising new cancer drugs are in late-stage trials
Date: 19 November 2004
Source: Forbes
Author: Matthew Herper, Robert Langreth
Medical News Summary (summary of medical news story as reported by Forbes): The pharmaceuticals industry is engaged in a war on cancer. Some of the promising new drugs that are in late-stage trials are: 572016 fights breast and bladder cancer; ABX-EGF fights colon cancer and other tumors; BAY-43-9006 fights advanced kidney cancer; PTK-787 fights colon cancer; Provenge fights prostate cancer; Revlimid fights myelodysplastic syndromes, SU11248 fights stomach cancer; and Telcyta fights ovarian cancer.
URL: http://www.forbes.com/sciencesandmedicine/2004/01/23/cx_mh_rl_cancertear.html
Related Disease Topics: Breast cancer, Bladder cancer, Colon cancer, Tumor, Prostate cancer, Myelodysplastic syndrome, Stomach cancer, Ovarian cancer
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Medication
- medication and breast cancer
- medication and bladder cancer
- medication and colon cancer
- medication and tumor
- medication and prostate cancer
- Medication and myelodysplastic syndrome
- medication and stomach cancer
- medication and ovarian cancer
- Research
- research and breast cancer
- research and bladder cancer
- research and colon cancer
- research and tumor
- research and prostate cancer
- Research and myelodysplastic syndrome
- research and stomach cancer
- research and ovarian cancer
Medical Tools & Articles:
Next articles:
Medical Articles: